Larsen & Toubro Vyoma Partners with Fortanix to Launch Confidential AI Solutions
L&T Vyoma has entered a strategic partnership with US-headquartered Fortanix to launch sovereign confidential computing solutions in India. Powered by NVIDIA technology, the service provides hardware-based security for AI workloads, specifically targeting highly regulated sectors like banking and government.
KFintech Launches Finex Platform to Enable Same-Day Physical SIP Registration
KFin Technologies has deployed its Finex transformation programme to automate the traditionally manual physical SIP registration process. By leveraging agentic AI and intelligent workflows, the company has reduced activation timelines from several weeks to a single day, significantly enhancing operational efficiency for asset management companies.
LTM Limited Launches BlueVerse RightLogic Cybersecurity Framework for AI Enterprises
LTM Limited has introduced BlueVerse RightLogic, a comprehensive cybersecurity assessment and risk assurance framework designed to secure enterprises as they scale AI adoption. The solution addresses autonomous AI-driven threats through a structured 4 to 6 week engagement model that prioritizes remediation across software supply chains and legacy systems.
Blue Cloud Softech Launches AI-CopWriter FIR Tool; TTM Revenue Hits ₹1,001.9 Cr
Blue Cloud Softech Solutions has successfully deployed AI-CopWriter, India's first AI-powered multilingual FIR recording application, for the Hyderabad City Police. The tool automates complaint transcription across ten languages, aiming to standardise registration across the city's police network.
Granules India Secures Sole First-to-File Status for Sodium Oxybate Generic in US
Granules India has achieved Sole First-to-File status for its Sodium Oxybate Extended-Release ANDA, a generic equivalent of LUMRYZ. This regulatory milestone provides a strategic advantage in the US complex generics market and potentially grants the company marketing exclusivity.
Zydus Lifesciences and Apollo Hospitals Partner to Launch Shield Multi-Cancer Detection Test
Zydus Lifesciences has entered into a Memorandum of Understanding with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection (MCD) test in India. This partnership utilizes Zydus's exclusive agreement with Guardant Health to provide a non-invasive, blood-based screening tool for 10 common cancer types.
RattanIndia Subsidiary Revolt Motors Launches RVX Electric Bike at ₹1.24 Lakh
Revolt Motors, a subsidiary of RattanIndia Enterprises, has introduced the RVX, its most powerful electric motorcycle to date. The model features a 5.3 kW peak power output and a 160 km range, targeting the performance-oriented urban commuter segment.
Iris Clothings Launches Newborn Gift Set Range to Expand Premium Infant Wear Portfolio
Iris Clothings Limited has officially entered the high-potential newborn gifting segment with a new range of curated apparel sets. This expansion leverages the company's integrated manufacturing model and a multi-channel distribution strategy to capture growth in the premium infant wear market.
Glenmark Pharmaceuticals Advances Phase 3 Trial for Trastuzumab rezetecan in Ovarian Cancer
Glenmark Specialty S.A. has advanced its multi-country Phase 3 clinical trial for Trastuzumab rezetecan, a HER2-targeted antibody-drug conjugate. India marks the initial site for patient enrollment following DCGI approval, with further expansion planned for Australia and South Korea.